Profil
David Pass is President & Chief Executive Officer at Altrixbio, Inc. since 2025 and Director at Gelesis Srl.
Former roles include Director-Marketing at Bristol-Myers Squibb Pharma Co. from 1994 to 2002, Vice President-Marketing at Johnson & Johnson from 2002 to 2008, Vice President-Marketing at Boehringer Ingelheim Corp.
from 2009 to 2016, Chief Operating & Commercial Officer at Gelesis, Inc. from 2016 to 2023, and Chief Operating & Commercial Officer at Gelesis Holdings, Inc. from 2022 to 2023.
Education includes undergraduate and doctorate degrees from Philadelphia College of Pharmacy.
Aktiva positioner av David Pass
| Företag | Position | Start |
|---|---|---|
Gelesis Srl
Gelesis Srl BiotechnologyHealth Technology Develops novel category of potential therapies for GI-related chronic diseases | Direktör/Styrelseledamot | - |
Altrixbio, Inc.
Altrixbio, Inc. Pharmaceuticals: MajorHealth Technology Develops novel drugs that targeting metabolic diseases and type 2 diabetes | Verkställande Direktör | 2025-09-16 |
Tidigare kända positioner av David Pass
| Företag | Position | Slut |
|---|---|---|
| GELESIS HOLDINGS, INC. | Verksamhetschef | 2023-10-30 |
| GELESIS INC | Verksamhetschef | 2023-10-01 |
Boehringer Ingelheim Corp.
Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets health care products | Försäljning & Marknadsföring | 2016-08-01 |
| JOHNSON & JOHNSON | Försäljning & Marknadsföring | 2008-01-01 |
Bristol-Myers Squibb Pharma Co. | Försäljning & Marknadsföring | 2002-07-01 |
David Passs utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 8 |
|---|---|
Johnson & Johnson
Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
Gelesis, Inc.
Gelesis, Inc. BiotechnologyHealth Technology Operates as biotechnology company which develops novel category of therapies for GI-related chronic diseases | Health Technology |
Boehringer Ingelheim Corp.
Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets health care products | Health Technology |
Bristol-Myers Squibb Pharma Co. | |
Philadelphia College of Pharmacy
Philadelphia College of Pharmacy Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gelesis Srl
Gelesis Srl BiotechnologyHealth Technology Develops novel category of potential therapies for GI-related chronic diseases | Health Technology |
Altrixbio, Inc.
Altrixbio, Inc. Pharmaceuticals: MajorHealth Technology Develops novel drugs that targeting metabolic diseases and type 2 diabetes | Health Technology |
Gelesis Holdings, Inc.
Gelesis Holdings, Inc. Medical SpecialtiesHealth Technology Develops superabsorbent hydrogel therapeutics for chronic gastrointestinal, weight management and diabetes | Health Technology |
















